Evidence map›Paper›PMID 27124663›Full record

ArticlePLoS neglected tropical diseases2016

The wMel Strain of Wolbachia Reduces Transmission of Chikungunya Virus in Aedes aegypti.

Matthew T Aliota, Emma C Walker, Alexander Uribe Yepes, Ivan Dario Velez, Bruce M Christensen, Jorge E Osorio

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 2 pooled it
32.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 2 syntheses or guidelines pooled it, 213 citations in OpenAlex.

  1. Transovarial transmission of mosquito-borne viruses: a systematic review.Frontiers in cellular and infection microbiology · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Research Trends and Collaborative Patterns inInternational journal of environmental research and public health · 2026
    Article
  7. Phylogeny ofParasite epidemiology and control · 2026
    Article
  8. Article
  9. The inhibition mechanism ofFrontiers in microbiology · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. ExploitingPathogens (Basel, Switzerland) · 2025
    Review
  15. Article
  16. Targeting the vector of arbovirusesBeilstein journal of nanotechnology · 2025
    Review
  17. Potential effect ofFrontiers in microbiology · 2025
    Article
  18. Article
  19. Article
  20. Microbiology spectrum · 2024
    Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Matthew T AliotaDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Emma C WalkerDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Alexander Uribe YepesPrograma de Estudio y Control de Enfermedades Tropicales (PECET), Universidad de Antioquia, Medellin, Colombia.
Ivan Dario VelezPrograma de Estudio y Control de Enfermedades Tropicales (PECET), Universidad de Antioquia, Medellin, Colombia.
Bruce M ChristensenDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Jorge E OsorioDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
University of Wisconsin–Madison · USUniversidad de Antioquia · CO

Funding

Evolution of Chikungunya Virus in Wolbachia Infected mosquitoesR21AI117413 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI OSORIO, JORGE E · 2015 to 2016
$421k
NIAID NIH HHS #AI117413-01NIAID NIH HHS R21 AI117413
6 · The paper itself

Abstract

backgroundNew approaches to preventing chikungunya virus (CHIKV) are needed because current methods are limited to controlling mosquito populations, and they have not prevented the invasion of this virus into new locales, nor have they been sufficient to control the virus upon arrival. A promising candidate for arbovirus control and prevention relies on the introduction of the intracellular bacterium Wolbachia into Aedes aegypti mosquitoes. This primarily has been proposed as a tool to control dengue virus (DENV) transmission; however, evidence suggests Wolbachia infections confer protection for Ae. aegypti against CHIKV. Although this approach holds much promise for limiting virus transmission, at present our understanding of the ability of CHIKV to infect, disseminate, and be transmitted by wMel-infected Ae. aegypti currently being used at Wolbachia release sites is limited. METHODOLOGY/PRINCIPAL

findingsUsing Ae. aegypti infected with the wMel strain of Wolbachia that are being released in Medellin, Colombia, we report that these mosquitoes have reduced vector competence for CHIKV, even with extremely high viral titers in the bloodmeal. In addition, we examined the dynamics of CHIKV infection over the course of four to seven days post feeding. Wolbachia-infected mosquitoes remained non-infective over the duration of seven days, i.e., no infectious virus was detected in the saliva when exposed to bloodmeals of moderate viremia, but CHIKV-exposed, wild type mosquitoes did have viral loads in the saliva consistent with what has been reported elsewhere. Finally, the presence of wMel infection had no impact on the lifespan of mosquitoes as compared to wild type mosquitoes following CHIKV infection. CONCLUSIONS/SIGNIFICANCE: These results could have an impact on vector control strategies in areas where Ae. aegypti are transmitting both DENV and CHIKV; i.e., they argue for further exploration, both in the laboratory and the field, on the feasibility of expanding this technology beyond DENV.

Indexed as

AntibiosisAedesAnimalsChikungunya FeverChikungunya virusDisease Transmission, InfectiousInsect VectorsSalivaSurvival AnalysisWolbachia

Identifiers

PMID27124663
PMCPMC4849757
OpenAlexW2343719003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.